HPR226 Uncertainties in Regulatory Benefit-Risk Decision Making for Innovative Anticancer Therapies: Preliminary Results From a 2011-2024 Review of Extensions of Indications
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.1633
https://www.valueinhealthjournal.com/article/S1098-3015(25)04190-7/fulltext
Title :
HPR226 Uncertainties in Regulatory Benefit-Risk Decision Making for Innovative Anticancer Therapies: Preliminary Results From a 2011-2024 Review of Extensions of Indications
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)04190-7&doi=10.1016/j.jval.2025.09.1633
First page :
Section Title :
Open access? :
No
Section Order :
11171